国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Pseudomonas aeruginosa Cytochrome c-type biogenesis protein CycH (cycH), partial CSB-YP881216EZX1
CSB-EP881216EZX1
CSB-BP881216EZX1
CSB-MP881216EZX1
CSB-EP881216EZX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Cytochrome c biogenesis ATP-binding export protein CcmA (ccmA) CSB-YP881217EZX
CSB-EP881217EZX
CSB-BP881217EZX
CSB-MP881217EZX
CSB-EP881217EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Cytochrome o ubiquinol oxidase protein CyoD (cyoD), partial CSB-YP881218EZX1
CSB-EP881218EZX1
CSB-BP881218EZX1
CSB-MP881218EZX1
CSB-EP881218EZX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Cobyrinic acid A,C-diamide synthase (cobB) CSB-YP881219EZX
CSB-EP881219EZX
CSB-BP881219EZX
CSB-MP881219EZX
CSB-EP881219EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa NAD-dependent protein deacylase 2 (cobB2) CSB-YP881220EZX
CSB-EP881220EZX
CSB-BP881220EZX
CSB-MP881220EZX
CSB-EP881220EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Periplasmic nitrate reductase (napA), partial CSB-YP881221EZX
CSB-EP881221EZX
CSB-BP881221EZX
CSB-MP881221EZX
CSB-EP881221EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Peptidoglycan hydrolase flgJ (flgJ) CSB-YP881222EZX
CSB-EP881222EZX
CSB-BP881222EZX
CSB-MP881222EZX
CSB-EP881222EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Nitronate monooxygenase (PA1024) CSB-YP881223EZX
CSB-EP881223EZX
CSB-BP881223EZX
CSB-MP881223EZX
CSB-EP881223EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Acylphosphatase (acyP) CSB-YP881224EZX
CSB-EP881224EZX
CSB-BP881224EZX
CSB-MP881224EZX
CSB-EP881224EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Acetyl-coenzyme A synthetase 1 (acsA1), partial CSB-YP881225EZX
CSB-EP881225EZX
CSB-BP881225EZX
CSB-MP881225EZX
CSB-EP881225EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Acetate kinase (ackA) CSB-YP881226EZX
CSB-EP881226EZX
CSB-BP881226EZX
CSB-MP881226EZX
CSB-EP881226EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Signal peptidase I (lepB), partial CSB-YP881227EZX
CSB-EP881227EZX
CSB-BP881227EZX
CSB-MP881227EZX
CSB-EP881227EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Iron-sulfur cluster insertion protein ErpA (erpA) CSB-YP881228EZX
CSB-EP881228EZX
CSB-BP881228EZX
CSB-MP881228EZX
CSB-EP881228EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Protein ApaG (apaG) CSB-YP881229EZX
CSB-EP881229EZX
CSB-BP881229EZX
CSB-MP881229EZX
CSB-EP881229EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 30S ribosomal protein S21 (rpsU) CSB-YP881230EZX
CSB-EP881230EZX
CSB-BP881230EZX
CSB-MP881230EZX
CSB-EP881230EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa ATP-dependent dethiobiotin synthetase BioD (bioD) CSB-YP881231EZX
CSB-EP881231EZX
CSB-BP881231EZX
CSB-MP881231EZX
CSB-EP881231EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa D-hydantoinase/dihydropyrimidinase (dht) CSB-YP881232EZX
CSB-EP881232EZX
CSB-BP881232EZX
CSB-MP881232EZX
CSB-EP881232EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Thiazole synthase (thiG) CSB-YP881233EZX
CSB-EP881233EZX
CSB-BP881233EZX
CSB-MP881233EZX
CSB-EP881233EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 3-dehydroquinate dehydratase 2 (aroQ2) CSB-YP881234EZX
CSB-EP881234EZX
CSB-BP881234EZX
CSB-MP881234EZX
CSB-EP881234EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Chemotaxis response regulator protein-glutamate methylesterase of group 2 operon (cheB2) CSB-YP881235EZX
CSB-EP881235EZX
CSB-BP881235EZX
CSB-MP881235EZX
CSB-EP881235EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>